ViiV registers two HIV studies: DDI trial for VH4011499 and NIAID-led PALACE trialNov 16Weekly roundup, 2 itemscabotegravirGilead Sciences
GSK's Benlysta label updated by FDA; Phase 2a NASH trial posts resultsOct 30Weekly roundup, 10 itemsaletekitugAmgenUpdated
GSK registers three new Phase 3 trials spanning asthma, prostate cancer, ovarian cancerOct 2Weekly roundup, 11 itemscabotegravirganfeboroleUpdated
GSK's IPF drug GSK3915393 fails Phase 2 on futility; expanded access opens for velzatinib in GISTSep 18Weekly roundup, 3 itemsGlaxoSmithKlineGSK3915393
NIAID-led IMPAACT 2026 pharmacokinetic study terminated early, results postedAug 26Trial updateGilead SciencesGlaxoSmithKline